Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer

Zhang L, Li N, Liu M, Zheng B, Wu Z, Cai H

Cancer Management and Research 2021, 13:4263-4270

Published Date: 28 May 2021